The Eugene, OR campus is a fully integrated CDMO hub designed to support small molecule programs from early discovery through commercial API manufacturing. The site combines a long-established R&D center with broad synthetic chemistry capabilities and a modern cGMP facility equipped for efficient clinical and commercial production.

The campus offers flexible cGMP suites (100–400 L), on site QC laboratories, and extensive analytical instrumentation to enable method development, validation, and rapid release testing. Its equipment and technical breadth—spanning complex organic synthesis, hydrogenation, preparative chromatography, specialized chemistries, and non-GMP scale-up—supports a wide range of API and intermediate challenges.

A mature quality system, MasterControl eQMS, and strong audit performance—including positive feedback from top pharmaceutical partners—underscore Agno Eugene’s reliability. With integrated development, analytical, and manufacturing capabilities, the Eugene site provides a responsive, chemistry-focused platform for advancing innovative API programs with speed and confidence.